Company

Suzhou Kintor Pharmaceutical

As of the edition of 20 October 2026, Suzhou Kintor Pharmaceutical runs 6 drugs.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active2
Went quiet1
Stopped2
Status not established1
Total6

Where its trials are

  • Skin and connective tissue: 8 trials led
  • Cancer: 5 trials led
  • Digestive system: 2 trials led